Search results
Author(s):
Charles Knight
,
Saidi Mohiddin
Added:
3 years ago
The management of patients with hypertrophic cardiomyopathy (HCM) requires expertise in heart failure, cardiac imaging, electrophysiology, genetic testing and counselling, and in techniques that reduce left ventricular outflow tract obstruction (LVOTO). Following the initial description of alcohol septal ablation (ASA) in 1995,1 it has gained rapid acceptance and is now the most commonly chosen…
View more
Eduardo A Arias
Author
Liam McCormick
Job title: Interventional & Structural Cardiologist
Author
Author(s):
Milind Y Desai
Added:
1 year ago
In this short summary interview, Dr Milind Y Desai (Cleveland Clinic, US) shares the findings from the VALOR-HCM trial (MyoKardia) (NCT04349072).
This randomised, multicentre study was designed to assess the effect of mavacamten treatment on reducing the number of septal reduction therapy (SRT) procedures performed in subjects with symptomatic obstructive hypertrophic cardiomyopathy.
Discussion…
View more
Author(s):
Lindsay A Smith
,
Amit Bhan
,
Mark J Monaghan
Added:
3 years ago
The field of non-coronary cardiac intervention is undergoing rapid expansion, driven by advances in technology and increasing demand for alternative, non-surgical therapies for common structural heart diseases. As a result, the volume, variety and complexity of percutaneous catheter-based procedures being performed in cardiac catheterisation laboratories are increasing. Traditionally, fluoroscopy…
View more
Annapoorna Kini
Job title: The Mount Sinai Hospital
Author
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
2 years ago
In this concise episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their analysis of the late-breaking trials that will be presented at ACC 2022.
Trials covered in detail include:
00:39: PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
Learn about the key take-home messages from ACC.22 with View from the Thoraxcenter hosts, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL).
In this succinct review video, they summarise the top late-breaking science trials and share their take on how the new data can be translated into practice.
Trials covered in detail include:
00:29: PACMAN AMI:…
View more
Alcohol and Heart Failure
Author(s):
Debar Rasoul
,
Ashwin Ajay
,
Alend Abdullah
,
et al
Added:
3 months ago
Article
Author(s):
Mary N Sheppard
Added:
3 years ago
Takotsubo syndrome is an acute reversible heart failure syndrome, which is increasingly recognised by coronary angiography for patients with acute ‘cardiac’ chest pain.1 It is a distinct disease entity from acute coronary syndrome, although the initial presentation has similar features to either ST elevation myocardial infarction (STEMI) or non-ST elevation myocardial infarction (NSTEMI). Early…
View more